Associate Director of Teacher Residency KIPP Public Schools Northern CaliforniaAssociate Director of Teacher ResidencyOakland, CA$104,000–$127,000 / yearThe Associate Director of Teacher Residency owns the implementation and continuous improvement of KIPP NorCal's teacher residency program, ensuring residents and mentor teachers receive the coaching, development, and support needed to grow into highly effective educators. This role serves as the primary instructional lead for the residency experience, partnering with school leaders, mentors, and Alder Graduate School of Education to develop a strong and diverse teacher pipeline for KIPP NorCal schools.
Director Emergency Services HCA HealthcareDirector Emergency ServicesSan Jose, CA$184,683.20–$276,848 / yearAdditional options for dental and vision benefits, life and disability coverage, flexible spending accounts, supplemental health protection plans (accident, critical illness, hospital indemnity), auto and home insurance, identity theft protection, legal counseling, long-term care coverage, moving assistance, pet insurance and more. The Director of Emergency Services ensures high quality, patient-centered care through oversight of the overall function and staffing of the unit(s) and department(s) in addition to forecasting, planning, and budget monitoring.
NewAssociate Director, Medical Review Lead, MSRM - Remote Agios PharmaceuticalsAssociate Director, Medical Review Lead, MSRM - RemoteSan Francisco, CARemote$185,369–$308,948 / yearThe current base salary range for this position is expected to be between $185,369 and $308,948 annualized; final salary will be determined based on various factors including, but not limited to, years of relevant experience, job knowledge, skills and proficiency, degree/education, and internal comparators. This role provides oversight of medical review for Individual Case Safety Reports (ICSRs) across investigational and marketed products, ensuring medical accuracy, regulatory compliance, and high-quality safety data to support pharmacovigilance and risk management activities.
Managing Principal / Senior Director, Data Analytics Consulting EPAM SystemsManaging Principal / Senior Director, Data Analytics ConsultingSan Jose, CAThis is a high-impact, client-facing role designed for an ambitious professional with deep technical expertise in AI & Data, proven consulting acumen, and a track record of driving transformational outcomes for enterprise clients. • Serve as a trusted strategic advisor to senior executives (VP, SVP, C-suite) on AI enablement, data-driven transformation, and operational efficiency for Fortune 500/50 clients.
NewClinical Director Psych-AllianceClinical DirectorSan Francisco, CaliforniaLocation: San Francisco Bay Area ( Los Altos & San Mateo) A growing, mission-driven behavioral health organization is seeking a Clinical Director to lead two outpatient clinics serving adults with Severe Mental Illness (SMI) in the San Francisco Peninsula. This role is perfect for a hands-on leader who thrives in growing organizations and enjoys building programs, developing teams, and driving high-quality patient care in a collaborative environment.
Associate Director, Clinical Quality Denali Therapeutics IncAssociate Director, Clinical QualitySouth San Francisco, CA$193,638–$224,270 / yearThe Associate Director, GCP Clinical Quality will play a key role in ensuring the successful execution of Denali's clinical trials by delivering strategic quality oversight and fostering a culture of compliance and continuous improvement. Key Accountabilities/Core Job Responsibilities: Serve as a GCP Quality team member on Study Execution Teams (SETs) and deliver a cohesive strategic GCP framework across Denali clinical trials.
Executive Director, Clinical Supply Chain Revolution Medicines, Inc.Executive Director, Clinical Supply ChainRedwood City, CA$265,000–$331,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Senior Director, Clinical Biomarker Operations Revolution Medicines, Inc.Senior Director, Clinical Biomarker OperationsRedwood City, CA$244,000–$305,000 / yearThe Opportunity: Revolution Medicines is seeking a strategic and experienced leader to serve as Senior Director, Clinical Biomarker Operations, responsible for leading the operational execution of biomarker and companion diagnostic (CDx) strategies across early- and late-stage clinical development programs. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
NewSenior Director, Real World Data RWD Freenome IncSenior Director, Real World Data RWDCARemote$236,300–$335,475 / yearAbout this opportunity: As the Senior Director of Real World Data (RWD), you will be accountable for defining, developing, and implementing our RWD strategy, platform, and data pipeline to transform diverse real-world datasets into regulatory-grade, research-ready assets that drive our clinical development, evidence generation, digital health products and product offerings. Specifically, the Senior Director will lead the RWD Informatics team in turning electronic health records (EHR), claims, imaging, and other RWD sources into research-ready datasets accessible by our biostatisticians,computational scientists and other end users while ensuring data quality, operational efficiency, and scalability.
Director of Operations Bay Area HyperbaricsDirector of OperationsLos Gatos, CA$125,000–$175,000 / yearThe ideal candidate is a hands-on healthcare leader who thrives in a fast-paced environment and has a proven track record of improving operational efficiency while building strong teams. This leadership role is responsible for operational performance, staff management, financial oversight, regulatory compliance, facility management, and delivering an exceptional patient experience.
NewAssociate Director, Project Management Alector IncAssociate Director, Project ManagementSouth San Francisco, CA$190,000–$220,000 / yearWe are supported in this mission by experienced and accomplished scientists and clinicians, a novel portfolio of programs, leading healthcare investors, and pharma company partners, who share in our commitment to bettering the lives of patients and realizing a world where we make brain disorders history. Reporting to the Head of Clinical Development, you will collaborate with leaders and subject matter experts across Research, Development, Clinical, Regulatory, CMC, and other functions to translate strategy into actionable plans, proactively manage risks, and accelerate program progress.
NewAssociate Director Workforce Planning Novotech Health Holdings Pte LtdAssociate Director Workforce PlanningSouth San Francisco, CA$160,000–$190,000 / yearThe Associate Director / Director Workforce Planning is responsible for defining and leading the global workforce planning strategy, operating model, and governance framework, ensuring scalable, data-driven workforce planning across the organization. By offering trust, flexibility, and autonomy through programs like NovoLife, our flexible benefits framework, we empower team members to create an effective work-life balance that delivers professional satisfaction and maximum results for clients.
Director, Program Management Revolution Medicines, Inc.Director, Program ManagementRedwood City, CA$211,000–$264,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The Director, Program Management partners with the Project Team Leader (PTL) on the translation of program strategy into an efficient execution plan; they understand the competitive landscape and clinical context to manage the cross-functional dependencies and connections.
Director, Regulatory Affairs (US Filing Lead) Revolution Medicines, Inc.Director, Regulatory Affairs (US Filing Lead)Redwood City, CA$211,000–$264,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Required Skills, Experience and Education: Degree in life sciences, pharmacy, medicine, or related fields with a minimum of 12 years in the pharmaceutical/biotech industry or relevant work experience and a minimum of 8 years in Regulatory Affairs including a regulatory strategy role.
NewDirector Engineering - AI/ML Stamford American International HospitalDirector Engineering - AI/MLPalo Alto, CA$112.39–$148.91 / hourBridge Research & Practice: Act as the primary technical liaison between your engineering team and partners in the Chief Data Science Officers lab, translating novel research into production-ready platform features. Modern MLOps: Implement and oversee robust MLOps practices, including state-of-the-art GenAI evaluation techniques in collaboration with the Chief Data Science Officer and the members of the GUIDE-AI lab ([Link to arXiv paper]).
Director, Regulatory Affairs - US Filing Lead Revolution Medicines, Inc.Director, Regulatory Affairs - US Filing LeadRedwood City, CA$211,000–$264,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Required Skills, Experience and Education: Degree in life sciences, pharmacy, medicine, or related fields with a minimum of 12 years in the pharmaceutical/biotech industry or relevant work experience and a minimum of 8 years in Regulatory Affairs including a regulatory strategy role.
Senior Director, Client Partner EPAM SystemsSenior Director, Client PartnerSan Jose, CAIn this role, you will act as the primary point of contact for clients, delivery teams, technology practices and consulting teams within the Life Sciences Business Unit, developing account strategies, architecting delivery approaches, building successful relationships and owning business results. • Shape solutions that bridge strategy and plans to real-world execution, properly scoping and pricing engagements with delivery team counterparts, establishing optimal operating models and project team organization, and leading the transition from the sales process to the delivery phase.
Director, Stability Management, Analytical Development And Quality Control Revolution Medicines, Inc.Director, Stability Management, Analytical Development And Quality ControlRedwood City, CA$211,000–$264,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Collaborate cross-functionally with teams in drug substance, drug product, supply chain, quality, regulatory, sourcing and other related team to ensure alignment of stability design and achieve stability study objectives.
NewClinical Nursing Director - $10,000 Sign on Bonus!! United Surgical Partners International Inc (USPI)Clinical Nursing Director - $10,000 Sign on Bonus!!San Ramon, CAFull timeThe Outpatient Surgical Center Clinical Director will oversee staff credentialing, preventative safety measures, risk management duties, and use their clinical and leadership experience to enhance patient care and improve clinical outcomes. The Ambulatory Surgical Services Clinical Director is responsible for the day-to-day operations of the operating room and implements process initiatives to improve efficiency of services and patient experience.
Senior Director, Molecule Global Regulatory Lead Revolution Medicines, Inc.Senior Director, Molecule Global Regulatory LeadRedwood City, CA$244,000–$305,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Provide strategic oversight for the planning and execution of major regulatory submissions, including INDs, CTAs, amendments, expedited designation requests, marketing applications, and lifecycle submissions.
Regional Insights And Engagement Director, Northeast Revolution Medicines, Inc.Regional Insights And Engagement Director, NortheastRedwood City, CARemote$231,000–$254,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Partner with Sales, Medical Affairs, Market Access, and Commercial Operations & Business Analytics teams to ensure alignment of RevMed's US commercialization strategy; Uncovers, prioritizes, and communicates market insights, challenges/barriers, and solutions to the organization.
Associate Director, Global Healthcare Compliance Operations Revolution Medicines, Inc.Associate Director, Global Healthcare Compliance OperationsRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Lead implementation, enhancement, validation, and lifecycle management of systems supporting HCP/HCO engagements, advisory boards, speaker programs, grants and sponsorships, third-party due diligence, transparency reporting, monitoring and auditing activities, compliance training and certifications.
Associate Director, Program Management Structure Therapeutics IncAssociate Director, Program ManagementSouth San Francisco, CAAbility to meet multiple deadlines across a variety of projects/programs Ability to effectively interact with individuals at all levels across the organization Demonstrated knowledge of project management practices, tools and methodology Knowledge of drug development process and inter-dependencies between key functions including research, CMC, non-clinical development, clinical development and operations, and regulatory affairs Ability to manage conflict, drive consensus, and promote decision-making Ability to independently identify and manage project objectives, timelines, budgets, providing formal and informal status updates to stakeholders as needed Proactive mindset, strong leadership, facilitation, teamwork, and influence management/ negotiation skills. The company's platform combines the latest advancements in visualization of molecular interactions, computational chemistry, and data integration to design orally available, superior small molecule medicines that overcome current limitations of biologic and peptide drugs.
Senior Director, Talent Acquisition & HRBP Maze Therapeutics IncSenior Director, Talent Acquisition & HRBPSouth San Francisco, CA$270,000–$330,000 / yearThe company is advancing a pipeline using its Compass platform, which allows it to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. Maze Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic diseases, including obesity.
NewSenior Director, Partnerships, Platform Go-to-Market Strategy & Activation Butterfly NetworkSenior Director, Partnerships, Platform Go-to-Market Strategy & ActivationSan Francisco, CAAs Senior Director, Strategic Partnerships, you will be responsible for sourcing, structuring, negotiating, and closing high-impact partnerships—including complex semiconductor, chip licensing, SDK, AI, and technology integration deals that fuel the growth of both platforms. Reporting directly to the Chief Business Officer, you will shape the commercial strategy for two of Butterfly's most important innovation engines: Butterfly Garden: expanding our AI and SDK partner network, integrating third-party AI models, and driving adoption of AI-powered clinical solutions.
Clinical Supervising Attorney & Lecturer in Law, Community Law Clinic Stanford UniversityClinical Supervising Attorney & Lecturer in Law, Community Law ClinicRedwood City, CAPreferred qualifications: Demonstrated commitment to rigorous, strategic, and reflective legal practice; Significant experience in direct legal services to low-income clients; Substantive legal knowledge in at least one domain of the CLC practice (e.g., housing, social security disability, public benefits, employment rights); Demonstrated commitment to asset-based and client-centered lawyering and partnerships; An understanding of and engagement with access to justice debates and innovations; Intentional cultivation of teamwork, collaboration, and interpersonal skills, including the ability to provide constructive feedback; Strong organizational / management skills; Ability to work in a self-directed and entrepreneurial environment; and. Independently supervise certified law students in direct services civil legal matters consistent with the MLC's pedagogical practice of non-directive supervision; Collaborate with CLC Director and Associate Director in designing and implementing all aspects of the CLC, including developing the clinic docket and co-creating the syllabus and curriculum; Facilitate training sessions, seminars and case rounds discussions as assigned; Foster a sense of deep and supportive community within the Clinic; and.
Licensed Clinical Program Manager CATHOLIC CHARITIES OF SANTA CLARA COUNTYLicensed Clinical Program ManagerSan Jose, CACoordinate Services with the Adult/Child psychiatrist, team members, primary care and specialist physicians, legal representatives/guardians, County Department of Behavioral Health-(Mental Health and Drug and Alcohol) staff, and other community services/organizations to ensure clients access to services and the quality of service delivery system. Excellent written and verbal communication skills in English; strong analytical and problem-solving skills; demonstrated ability to foster consensus and teamwork; strong organizational skills (ability to prioritize, manage multiple projects, and meet deadlines).
Director, Regulatory Affairs US Filing Lead Revolution Medicines IncDirector, Regulatory Affairs US Filing LeadRedwood City, CA$211,000–$264,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Required Skills, Experience and Education: Degree in life sciences, pharmacy, medicine, or related fields with a minimum of 12 years in the pharmaceutical/biotech industry or relevant work experience and a minimum of 8 years in Regulatory Affairs including a regulatory strategy role.
Director, Regulatory Affairs Global Filing Lead Revolution Medicines IncDirector, Regulatory Affairs Global Filing LeadRedwood City, CA$211,000–$264,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Required Skills, Experience and Education: Degree in life sciences, pharmacy, medicine, or related fields with a minimum of 12 years in the pharmaceutical/biotech industry or relevant work experience and a minimum of 8 years in Regulatory Affairs including a regulatory strategy role.
Senior Director, Molecule Global Regulatory Lead Revolution Medicines IncSenior Director, Molecule Global Regulatory LeadRedwood City, CA$244,000–$305,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Provide strategic oversight for the planning and execution of major regulatory submissions, including INDs, CTAs, amendments, expedited designation requests, marketing applications, and lifecycle submissions.
Regional Insights and Engagement Director, Lung, Central Rockies Revolution Medicines IncRegional Insights and Engagement Director, Lung, Central RockiesRedwood City, CARemote$231,000–$254,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Partner with Sales, Medical Affairs, Market Access, and Commercial Operations & Business Analytics teams to ensure alignment of RevMed's US commercialization strategy; Uncovers, prioritizes, and communicates market insights, challenges/barriers, and solutions to the organization.
Associate Director, Global Healthcare Compliance Operations Revolution Medicines IncAssociate Director, Global Healthcare Compliance OperationsRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Lead implementation, enhancement, validation, and lifecycle management of systems supporting HCP/HCO engagements, advisory boards, speaker programs, grants and sponsorships, third-party due diligence, transparency reporting, monitoring and auditing activities, compliance training and certifications.
Director, Stability Management, Analytical Development and Quality Control Revolution Medicines IncDirector, Stability Management, Analytical Development and Quality ControlRedwood City, CA$211,000–$264,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Collaborate cross-functionally with teams in drug substance, drug product, supply chain, quality, regulatory, sourcing and other related team to ensure alignment of stability design and achieve stability study objectives.
Director, Program Management Revolution Medicines IncDirector, Program ManagementRedwood City, CA$211,000–$264,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The Director, Program Management partners with the Project Team Leader (PTL) on the translation of program strategy into an efficient execution plan; they understand the competitive landscape and clinical context to manage the cross-functional dependencies and connections.
Regional Insights and Engagement Director, Northeast Revolution Medicines IncRegional Insights and Engagement Director, NortheastRedwood City, CARemote$231,000–$254,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Partner with Sales, Medical Affairs, Market Access, and Commercial Operations & Business Analytics teams to ensure alignment of RevMed's US commercialization strategy; Uncovers, prioritizes, and communicates market insights, challenges/barriers, and solutions to the organization.
Director, Regulatory Affairs - US Filing Lead Revolution Medicines IncDirector, Regulatory Affairs - US Filing LeadRedwood City, CA$211,000–$264,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Required Skills, Experience and Education: Degree in life sciences, pharmacy, medicine, or related fields with a minimum of 12 years in the pharmaceutical/biotech industry or relevant work experience and a minimum of 8 years in Regulatory Affairs including a regulatory strategy role.
Regional Insights and Engagement Director, Lung, Southeast Revolution Medicines IncRegional Insights and Engagement Director, Lung, SoutheastRedwood City, CARemote$231,000–$254,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Partner with Sales, Medical Affairs, Market Access, and Commercial Operations & Business Analytics teams to ensure alignment of RevMed's US commercialization strategy; Uncovers, prioritizes, and communicates market insights, challenges/barriers, and solutions to the organization.
Regional Insights and Engagement Director, Lung, Central Rockies Revolution MedicinesRegional Insights and Engagement Director, Lung, Central RockiesRedwood City, CaliforniaRemoteThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Partner with Sales, Medical Affairs, Market Access, and Commercial Operations & Business Analytics teams to ensure alignment of RevMed’s US commercialization strategy; Uncovers, prioritizes, and communicates market insights, challenges/barriers, and solutions to the organization.
Senior Director, Molecule Global Regulatory Lead Revolution MedicinesSenior Director, Molecule Global Regulatory LeadRedwood City, CaliforniaThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Provide strategic oversight for the planning and execution of major regulatory submissions, including INDs, CTAs, amendments, expedited designation requests, marketing applications, and lifecycle submissions.
Director, Stability Management, Analytical Development and Quality Control Revolution MedicinesDirector, Stability Management, Analytical Development and Quality ControlRedwood City, CaliforniaThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Collaborate cross-functionally with teams in drug substance, drug product, supply chain, quality, regulatory, sourcing and other related team to ensure alignment of stability design and achieve stability study objectives.
Director, Program Management Revolution MedicinesDirector, Program ManagementRedwood City, CaliforniaThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The Director, Program Management partners with the Project Team Leader (PTL) on the translation of program strategy into an efficient execution plan; they understand the competitive landscape and clinical context to manage the cross-functional dependencies and connections.
Regional Insights and Engagement Director, Northeast Revolution MedicinesRegional Insights and Engagement Director, NortheastRedwood City, CaliforniaRemoteThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Partner with Sales, Medical Affairs, Market Access, and Commercial Operations & Business Analytics teams to ensure alignment of RevMed’s US commercialization strategy; Uncovers, prioritizes, and communicates market insights, challenges/barriers, and solutions to the organization.
Director, Regulatory Affairs (Global Filing Lead) Revolution MedicinesDirector, Regulatory Affairs (Global Filing Lead)Redwood City, CaliforniaThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Degree in life sciences, pharmacy, medicine, or related fields with a minimum of 12 years in the pharmaceutical/biotech industry or relevant work experience and a minimum of 8 years in Regulatory Affairs including a regulatory strategy role.
Director, Regulatory Affairs - US Filing Lead Revolution MedicinesDirector, Regulatory Affairs - US Filing LeadRedwood City, CaliforniaThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Degree in life sciences, pharmacy, medicine, or related fields with a minimum of 12 years in the pharmaceutical/biotech industry or relevant work experience and a minimum of 8 years in Regulatory Affairs including a regulatory strategy role.
Director, Regulatory Affairs (US Filing Lead) Revolution MedicinesDirector, Regulatory Affairs (US Filing Lead)Redwood City, CaliforniaThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Degree in life sciences, pharmacy, medicine, or related fields with a minimum of 12 years in the pharmaceutical/biotech industry or relevant work experience and a minimum of 8 years in Regulatory Affairs including a regulatory strategy role.
Associate Director, Global Healthcare Compliance Operations Revolution MedicinesAssociate Director, Global Healthcare Compliance OperationsRedwood City, CaliforniaThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Lead implementation, enhancement, validation, and lifecycle management of systems supporting HCP/HCO engagements, advisory boards, speaker programs, grants and sponsorships, third-party due diligence, transparency reporting, monitoring and auditing activities, compliance training and certifications.
Regional Insights and Engagement Director, Lung, Southeast Revolution MedicinesRegional Insights and Engagement Director, Lung, SoutheastRedwood City, CaliforniaRemoteThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Partner with Sales, Medical Affairs, Market Access, and Commercial Operations & Business Analytics teams to ensure alignment of RevMed’s US commercialization strategy; Uncovers, prioritizes, and communicates market insights, challenges/barriers, and solutions to the organization.
Senior Director, Talent Acquisition & Hrbp Maze TherapeuticsSenior Director, Talent Acquisition & HrbpSouth San Francisco, CA$270,000–$330,000 / yearOur clinical pipeline is anchored by two small molecule programs: MZE829, an APOL1 inhibitor for patients with APOL1‑mediated kidney disease, and MZE782, which targets genetic drivers of disease in phenylketonuria (PKU) and chronic kidney disease. We are seeking a Senior Director, Talent Acquisition & HRBP to lead hiring strategy and execution as the company advances its lead program into late‑stage development and prepares for continued organizational growth.
Senior Director, Talent Acquisition & HRBP Maze TherapeuticsSenior Director, Talent Acquisition & HRBPSouth San Francisco, CA$270,000–$330,000 / yearThe company is advancing a pipeline using its Compass platform, which allows it to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. Maze Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic diseases, including obesity.
Board Certified Behavior Analyst (BCBA), Clinical Director - San Jose, CA BlueSprigBoard Certified Behavior Analyst (BCBA), Clinical Director - San Jose, CASan Jose, California$103,000–$108,000 / yearAs our Board Certified Behavior Analyst CD, you’ll develop and lead a team of behavior technicians and clinical supervisors, influence the direction of the center, and work with families and clinicians to deliver tailored high quality ABA therapy. Career Growth With our nationwide network of ~160 centers, you’ll have opportunities to advance your career in both clinical and operational paths - plus unique chances to participate in cutting-edge research through SprigLAB .